Table of Contents
Is Divis Lab a good company?
Divis laboratories is a good company to work with. You will get wide range of exposure in this company. According to safety , E. H. S, quality , GMP norms it would stands one of the greatest companies in india.
What is the work of Divis Lab?
Divi’s Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies.
What are the products of Divis Lab?
Divis Laboratories Products
- Beta-Carotene 20% DC/AF.
- Lutein 20% SAF.
- Beta-Carotene 10% DG.
- Beta-Carotene 7.5% DC/AF.
- Beta-Carotene 10% DC/AF.
- Lutein 5% DC/AFG.
- Beta-Carotene 20% DC.
- Natural Beta-Carotene 1% SD/N.
Is Divis Lab good for long term?
The company’s healthy balance sheet and recent correction in stock price make it a good buy for the long term.
Is Divis a MNC company?
Divi’s Laboratories Limited is an Indian multinational Pharmaceuticals company and producer of active pharmaceutical ingredients (APIs) and intermediates headquartered in Hyderabad, Telangana, India. The company manufactures and custom synthesizes generic APIs, intermediates and nutraceutical ingredients.
What is the intrinsic value of Divis Lab?
Divis Laboratories
| As Of | Intrinsic Value | Market Price |
|---|---|---|
| 31 Mar 2022 | Rs. 2,160.53 | Rs. 4,402.05 |
| 8 Jun 2022 | —- | Rs. 3,495.30 |
| -5.95 -0.17% |
Is Divis Lab Large Cap?
Divi’s Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 122688.96 Crore) operating in Pharmaceuticals sector.
Why is Divis Labs falling?
So one reason why Divi’s Lab is falling is that the high growth it saw last year seems unsustainable going forward. The profit margins were also running high due to Covid-19. Now, with the Covid-19 situation normalising everywhere, it is expected the company will face a lower growth base and reduced margins.
Who are the promoters of Divis Lab?
Divi’s Laboratories
| Divi’s Laboratories’ logo | |
|---|---|
| Formerly | Divi’s Research Centre |
| Total equity | ₹7,309.92 crore (US$960 million) (2020) |
| Owner | Divi Satchandra Kiran (20.34%) Nilima Motaparti (20.34%) Divi Swarna Latha (5.27%) Divis Biotech Private Limited (3.01%) Murali Krishna Prasad Divi (2.85%) |
| Number of employees | 13,884 (2020) |
What is P E ratio of Divis Lab?
The Current P/E Ratio of DIVIS LABORATORIES is 48.04.